Selection of a Moxifloxacin Dose That Suppresses Drug Resistance inMycobacterium tuberculosis,by Use of an In Vitro Pharmacodynamic Infection Model and Mathematical Modeling
The Journal of Infectious Diseases2004Vol. 190(9), pp. 1642–1651
Citations Over TimeTop 10% of 2004 papers
Abstract
A moxifloxacin dose of 800 mg/day is likely to achieve excellent M. tuberculosis microbial kill and to suppress drug resistance. However, tolerability of this higher dose is still unknown.
Related Papers
- → Moxifloxacin-Mediated Killing of Mycobacterium tuberculosis Involves Respiratory Downshift, Reductive Stress, and Accumulation of Reactive Oxygen Species(2022)75 cited
- → Pharmacokinetics and pharmacodynamics of SCT800, a new recombinant FVIII, in hemophilia A mice(2016)6 cited
- → Safety of Moxifloxacin as Shown in Animal and In Vitro Studies(2005)35 cited
- → The Effects of Moxifloxacin on QTc Interval in Healthy Korean Male Subjects(2014)13 cited
- → Shorter moxifloxacin-based regimens for drug-sensitive tuberculosis.(2015)15 cited